Persephone Biosciences
Persephone Biosciences, formerly known as Persephone Biome, is a healthcare company based in San Diego, CA, specializing in the development of live biotherapeutic products to modulate gut microbiome metabolism for disease prevention and treatment.
Services
Persephone Biosciences develops live biotherapeutic products aimed at modulating the metabolism of gut microbes for disease prevention and cure. The company employs an engineering approach utilizing systems and synthetic biology to understand and influence the microbiome. Their services are rooted in harnessing the microbiome's potential as a pathway for medical treatments.
History
Formerly known as Persephone Biome, Persephone Biosciences was part of the Y-Combinator W18 batch. The company is located in San Diego, CA, and focuses on leveraging the microbiome for therapeutic purposes. Over the years, they have initiated several major studies to expand the understanding and application of the microbiome in healthcare.
Key Studies and Initiatives
Persephone Biosciences has launched notable studies, including the AMBROSIA study, focused on understanding how diet and lifestyle impact the gut microbiome, and My Baby Biome™ clinical study, which seeks to understand the microbiome's relationship from birth. Their ARGONAUT study is the largest in the US to map the gut and immune health of cancer patients, with the goal of unlocking biomarkers for the development of cancer therapeutics. The Poop for the Cure® initiative aims at gathering large-scale, real-world data with an emphasis on racial and ethnic diversity.
Location
Persephone Biosciences is headquartered in San Diego, California, USA. The company operates primarily within the United States and the broader America/Canada regions.
Industry Focus
Operating within the healthcare industry, Persephone Biosciences specializes in the sub-industry of therapeutics. Their primary focus is on developing microbiome-based biotherapeutic products that can prevent and cure diseases by modulating gut microbes.